Health Canada — Medical Devices · Canada · 2018-11-15 · Type III
As described by Health Canada — Medical Devices: CDI Blood Parameter Monitoring System 500 H/Sat Probe Assembly (2018-10-10)
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: A specific subset of the h/sat probe assembly population is being withdrawn due to a supplied component in the optics, the optical module. A change by the supplier to a different material and anodization resulted in increased failures. The CDI System 500 monitor conducts an automated self-test when the device is powered on. If the monitor contains an affected component, a color chip test failure will occur and the h/sat probe will be disabled.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.